Nolato Stock Price, News & Analysis
Company Description
Nolato (OTC Link: NLTBF) is a publicly traded medical devices company in the Healthcare sector. The company has a market capitalization of $1.6B.
NLTBF stock has gained 8.8% over the past year. Shares last traded at $6.53.
This page provides a comprehensive overview of NLTBF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Nolato (NLTBF) stock last traded at $6.53. Over the past 12 months, the stock has gained 8.8%. At a market capitalization of $1.6B, NLTBF is classified as a small-cap stock with approximately 241.8M shares outstanding.
Latest News
Nolato has 1 recent news article. View all NLTBF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Nolato (NLTBF) currently stands at 100 shares, down 94.2% from the previous reporting period, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 98.7%. This relatively low short interest suggests limited bearish sentiment. With 1000.0 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Nolato (NLTBF) currently stands at 1000.0 days. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The ratio has shown significant volatility over the period, ranging from 23.0 to 1000.0 days.
NLTBF Company Profile & Sector Positioning
Nolato (NLTBF) operates in the Medical Devices industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing NLTBF often look at related companies in the same sector, including Elekta Ab (EKTAF), Elekta Ab (EKTAY), Draegerwerk (DGWPF), Kuros Bioscience (CSBTF), and Phc Hldgs (PHCCF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate NLTBF's relative position within its industry.